Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
HY ›
HYALOTEND
Trademark search for:
HYALOTEND
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-10-12 — Application filed
2017-04-13 — Sn assigned for sect 66a appl from ib
2017-04-15 — Application filed
2017-04-15 — Assigned to examiner
2017-04-19 — Application filed
2017-04-21 — Final disposition recorded
2017-04-22 — Office action issued
2017-04-25 — Office action issued
2017-04-25 — Office action issued
2017-05-13 — Office action issued
2017-10-23 — Correspondence received in law office
2017-10-23 — Office action issued
2017-10-24 — Teas/email correspondence entered
2017-10-30 — Approved for pub - principal register
2017-11-22 — Notification of notice of publication e-mailed
2017-11-22 — Notification of possible opposition sent to ib
2017-11-22 — Notice of start of opposition period created, to be sent to ib
2017-12-08 — Notification processed by ib
2017-12-12 — Published for opposition
2017-12-12 — Official gazette publication confirmation e-mailed
2018-02-27 — Registered-principal register
2018-05-27 — Final disposition recorded
2018-06-06 — Final disposition recorded
2018-06-06 — Final disposition recorded
2018-06-29 — Final disposition recorded
2020-01-30 — Change of name/address rec'd from ib
2020-03-06 — Change of name/address rec'd from ib
2023-02-27 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-09-13 — Cancelled section 71
2024-09-13 — Final status recorded
2025-05-13 — Total invalidation of reg ext protection created
2025-09-05 — Invalidation processed
2025-09-05 — Total invalidation of reg ext protection sent to ib
2025-09-27 — Total invalidation processed by the ib
Owner Information
FIDIA FARMACEUTICI S.p.A.
FIDIA FARMACEUTICI S.p.A.
FIDIA FARMACEUTICI S.p.A.
Correspondent
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
